{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:50:48Z","timestamp":1784807448439,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["202233"],"award-info":[{"award-number":["202233"]}]},{"name":"Science and Technology Projects of Huai'an City","award":["HAB2024001"],"award-info":[{"award-number":["HAB2024001"]}]},{"name":"Research Project of Northern Jiangsu Institute of Clinical Medicine, Nanjing Medical University,","award":["SLKYQN20240132"],"award-info":[{"award-number":["SLKYQN20240132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03050-z","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:58:53Z","timestamp":1755748733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FBXO42 promotes hepatocellular carcinoma progression via mediating p57Kip2 ubiquitination and degradation"],"prefix":"10.1186","volume":"30","author":[{"given":"Bing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"1","key":"3050_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s40001-024-02073-2","volume":"29","author":"AR Devan","year":"2024","unstructured":"Devan AR, Nair B, Pradeep GK, et al. The role of glypican-3 in hepatocellular carcinoma: insights into diagnosis and therapeutic potential. Eur J Med Res. 2024;29(1):490.","journal-title":"Eur J Med Res"},{"key":"3050_CR2","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L, et al. Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr Mol Pharmacol. 2024;17: e18761429310703.","journal-title":"Curr Mol Pharmacol"},{"issue":"15","key":"3050_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"issue":"6","key":"3050_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606.","journal-title":"J Hepatol"},{"issue":"2","key":"3050_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","volume":"68","author":"M Boyle","year":"2018","unstructured":"Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease. J Hepatol. 2018;68(2):251\u201367.","journal-title":"J Hepatol"},{"issue":"5","key":"3050_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.cgh.2022.06.032","volume":"21","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Tan DJH, Ng CH, et al. Hepatocellular carcinoma incidence in alcohol-associated cirrhosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21(5):1169\u201377.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3050_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cancergen.2024.10.005","volume":"288\u2013289","author":"G Liu","year":"2024","unstructured":"Liu G, Lin W, Zhang K, et al. Elucidating the prognostic and therapeutic significance of TOP2A in various malignancies. Cancer Genet. 2024;288\u2013289:68\u201381.","journal-title":"Cancer Genet"},{"issue":"3","key":"3050_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000521596","volume":"11","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhang W, Bi X, et al. Systemic therapy for hepatocellular carcinoma: Chinese consensus-based interdisciplinary expert statements. Liver Cancer. 2022;11(3):192\u2013208.","journal-title":"Liver Cancer"},{"key":"3050_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107514","volume":"210","author":"S Liu","year":"2024","unstructured":"Liu S, Yang Y, Hou X, et al. Role for the F-box proteins in heart diseases. Pharmacol Res. 2024;210: 107514.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3050_CR10","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-024-49087-2","volume":"15","author":"L Luo","year":"2024","unstructured":"Luo L, Wu X, Fan J, et al. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nat Commun. 2024;15(1):4790.","journal-title":"Nat Commun"},{"issue":"39","key":"3050_CR11","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1038\/s41388-023-02809-0","volume":"42","author":"X Qiao","year":"2023","unstructured":"Qiao X, Lin J, Shen J, et al. FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation. Oncogene. 2023;42(39):2878\u201391.","journal-title":"Oncogene"},{"issue":"1","key":"3050_CR12","doi-asserted-by":"publisher","first-page":"18697","DOI":"10.1038\/s41598-024-69760-2","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li Q, Deng X, et al. Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma. Sci Rep. 2024;14(1):18697.","journal-title":"Sci Rep"},{"issue":"38","key":"3050_CR13","doi-asserted-by":"publisher","first-page":"eabq4831","DOI":"10.1126\/sciadv.abq4831","volume":"8","author":"H Jiang","year":"2022","unstructured":"Jiang H, Bian W, Sui Y, et al. FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ. Sci Adv. 2022;8(38):eabq4831.","journal-title":"Sci Adv"},{"issue":"W1","key":"3050_CR14","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3050_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","volume":"16","author":"Q Lian","year":"2018","unstructured":"Lian Q, Wang S, Zhang G, et al. Hccdb: a database of hepatocellular carcinoma expression atlas. Genom Proteom Bioinform. 2018;16(4):269\u201375.","journal-title":"Genom Proteom Bioinform"},{"issue":"D1","key":"3050_CR16","doi-asserted-by":"publisher","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, He M, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50(D1):D719\u201328.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3050_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40001-024-01711-z","volume":"29","author":"T Abdul-Rahman","year":"2024","unstructured":"Abdul-Rahman T, Ghosh S, Badar SM, et al. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review. Eur J Med Res. 2024;29(1):124.","journal-title":"Eur J Med Res"},{"key":"3050_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101119","volume":"27","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, He J, Zhang H, et al. Recent advances in the development of tumor microenvironment-activatable nanomotors for deep tumor penetration. Mater Today Bio. 2024;27: 101119.","journal-title":"Mater Today Bio"},{"key":"3050_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cancergen.2023.07.007","volume":"276\u2013277","author":"X Zeng","year":"2023","unstructured":"Zeng X, Huang X, Yin L, et al. Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer. Cancer Genet. 2023;276\u2013277:60\u20139.","journal-title":"Cancer Genet"},{"key":"3050_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217084","volume":"597","author":"YM Tsui","year":"2024","unstructured":"Tsui YM, Tian L, Lu J, et al. Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression. Cancer Lett. 2024;597: 217084.","journal-title":"Cancer Lett"},{"key":"3050_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217420","volume":"611","author":"C Wang","year":"2024","unstructured":"Wang C, Dong D, Zhao N, et al. Tumor-derived CCL15 regulates RNA m(6)A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth. Cancer Lett. 2024;611: 217420.","journal-title":"Cancer Lett"},{"issue":"25","key":"3050_CR22","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1073\/pnas.0901864106","volume":"106","author":"L Sun","year":"2009","unstructured":"Sun L, Shi L, Li W, et al. JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation. Proc Natl Acad Sci U S A. 2009;106(25):10195\u2013200.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3050_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3389\/fcell.2020.584590","volume":"8","author":"J Creff","year":"2020","unstructured":"Creff J, Besson A. Functional versatility of the CDK inhibitor p57(Kip2). Front Cell Dev Biol. 2020;8:584\u201390.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"3050_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.28372","volume":"63","author":"H Guo","year":"2016","unstructured":"Guo H, Jing L, Cheng Y, et al. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1\/Csn5 in hepatocarcinogenesis. Hepatology. 2016;63(3):898\u2013913.","journal-title":"Hepatology"},{"key":"3050_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.biopha.2018.11.080","volume":"110","author":"J Wang","year":"2019","unstructured":"Wang J, Zhao H, Yu J, et al. MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR)-based radiotherapy. Biomed Pharmacother. 2019;110:646\u201355.","journal-title":"Biomed Pharmacother"},{"key":"3050_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-024-00861-w","author":"Z Lei","year":"2025","unstructured":"Lei Z, Luo Y, Lu J, et al. FBXO22 promotes HCC angiogenesis and metastasis via RPS5\/AKT\/HIF-1\u03b1\/VEGF-A signaling axis. Cancer Gene Ther. 2025. https:\/\/doi.org\/10.1038\/s41417-024-00861-w.","journal-title":"Cancer Gene Ther"},{"key":"3050_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.930220","volume":"12","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen X, Zhou L, et al. FBXO9 mediates the cancer-promoting effects of ZNF143 by degrading FBXW7 and facilitates drug resistance in hepatocellular carcinoma. Front Oncol. 2022;12: 930220.","journal-title":"Front Oncol"},{"issue":"615","key":"3050_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh1486","volume":"13","author":"AC Bellail","year":"2021","unstructured":"Bellail AC, Jin HR, Lo HY, et al. Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors. Sci Transl Med. 2021;13(615): eabh1486.","journal-title":"Sci Transl Med"},{"key":"3050_CR29","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202009167","author":"P Barbosa","year":"2021","unstructured":"Barbosa P, Zhaunova L, Debilio S, et al. SCF-Fbxo42 promotes synaptonemal complex assembly by downregulating PP2A-B56. J Cell Biol. 2021. https:\/\/doi.org\/10.1083\/jcb.202009167.","journal-title":"J Cell Biol"},{"issue":"2","key":"3050_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae021","volume":"6","author":"P Hoellerbauer","year":"2024","unstructured":"Hoellerbauer P, Kufeld M, Arora S, et al. FBXO42 activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers. NAR Cancer. 2024;6(2): zcae021.","journal-title":"NAR Cancer"},{"issue":"6","key":"3050_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s44320-024-00032-x","volume":"20","author":"Y L\u00fc","year":"2024","unstructured":"L\u00fc Y, Cho T, Mukherjee S, et al. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. Mol Syst Biol. 2024;20(6):719\u201340.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"3050_CR32","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1038\/s41467-023-40327-5","volume":"14","author":"X Huang","year":"2023","unstructured":"Huang X, Liu X, Li X, et al. Cullin-associated and neddylation-dissociated protein 1 (CAND1) alleviates NAFLD by reducing ubiquitinated degradation of ACAA2. Nat Commun. 2023;14(1):4620.","journal-title":"Nat Commun"},{"issue":"3","key":"3050_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41419-021-03550-w","volume":"12","author":"N Shao","year":"2021","unstructured":"Shao N, Cheng J, Huang H, et al. GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2. Cell Death Dis. 2021;12(3):253.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3050_CR34","volume":"17","author":"DV Lim","year":"2024","unstructured":"Lim DV, Woo WH, Lim JX, et al. Targeting mutant-p53 for cancer treatment: are we there yet? Curr Mol Pharmacol. 2024;17(1): e140923221042.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"3050_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70533","volume":"14","author":"H Xing","year":"2025","unstructured":"Xing H, Liu D, Li J, et al. TERTp mutation and its prognostic value in glioma patients under the 2021 WHO classification: a real-world study. Cancer Med. 2025;14(2): e70533.","journal-title":"Cancer Med"},{"issue":"4","key":"3050_CR36","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s12072-024-10678-2","volume":"18","author":"M Oshi","year":"2024","unstructured":"Oshi M, Chida K, Roy AM, et al. Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome. Hepatol Int. 2024;18(4):1299\u2013309.","journal-title":"Hepatol Int"},{"issue":"14","key":"3050_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70027","volume":"13","author":"L Wang","year":"2024","unstructured":"Wang L, Yang L, Guan F, et al. TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas. Cancer Med. 2024;13(14): e70027.","journal-title":"Cancer Med"},{"issue":"1","key":"3050_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12072-023-10538-5","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu Y, He M, Ke X, et al. Centrosome amplification-related signature correlated with immune microenvironment and treatment response predicts prognosis and improves diagnosis of hepatocellular carcinoma by integrating machine learning and single-cell analyses. Hepatol Int. 2024;18(1):108\u201330.","journal-title":"Hepatol Int"},{"issue":"1","key":"3050_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12935-024-03489-w","volume":"24","author":"Q Li","year":"2024","unstructured":"Li Q, Yang W, Zhang Q, et al. Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1. Cancer Cell Int. 2024;24(1):315.","journal-title":"Cancer Cell Int"},{"key":"3050_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101191","volume":"28","author":"X Bao","year":"2024","unstructured":"Bao X, Sun M, Meng L, et al. Applications of pyroptosis activators in tumor immunotherapy. Mater Today Bio. 2024;28: 101191.","journal-title":"Mater Today Bio"},{"issue":"1","key":"3050_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","volume":"24","author":"X Su","year":"2025","unstructured":"Su X, Yan X, Zhang H. The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine. Mol Cancer. 2025;24(1):173.","journal-title":"Mol Cancer"},{"issue":"1","key":"3050_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","volume":"40","author":"RJ Tesi","year":"2019","unstructured":"Tesi RJ. MDSC; the most important cell you have never heard of. Trends Pharmacol Sci. 2019;40(1):4\u20137.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"3050_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27(1):109\u201318.","journal-title":"Cell Res"},{"key":"3050_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113244","author":"R P\u00e9REZ-TOM\u00e1S","year":"2020","unstructured":"P\u00e9REZ-TOM\u00e1S R, P\u00e9REZ-GUILL\u00e9N I. Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12113244.","journal-title":"Cancers (Basel)"},{"key":"3050_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061461","author":"P Caini","year":"2025","unstructured":"Caini P, Carloni V. Metabolism and immune suppressive response in liver cancer. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13061461.","journal-title":"Biomedicines"},{"key":"3050_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-032414-112043","volume":"33","author":"SR Woo","year":"2015","unstructured":"Woo SR, Corrales L, Gajewski TF. Innate immune recognition of cancer. Annu Rev Immunol. 2015;33:445\u201374.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3050_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12072-023-10615-9","volume":"18","author":"CL Yang","year":"2024","unstructured":"Yang CL, Song R, Hu JW, et al. Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma. Hepatol Int. 2024;18(1):73\u201390.","journal-title":"Hepatol Int"},{"issue":"11","key":"3050_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-024-07195-3","volume":"15","author":"G Fan","year":"2024","unstructured":"Fan G, Gao R, Xie T, et al. DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma. Cell Death Dis. 2024;15(11):797.","journal-title":"Cell Death Dis"},{"key":"3050_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043941","author":"H AKK\u0131Z","year":"2023","unstructured":"AKK\u0131Z H. Emerging role of cancer-associated fibroblasts in progression and treatment of hepatocellular carcinoma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043941.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3050_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-022-00406-z","volume":"10","author":"H Peng","year":"2022","unstructured":"Peng H, Zhu E, Zhang Y. Advances of cancer-associated fibroblasts in liver cancer. Biomark Res. 2022;10(1):59.","journal-title":"Biomark Res"},{"key":"3050_CR51","doi-asserted-by":"publisher","unstructured":"Zheng M, Liu L, Cui H, et al. Cancer-associated fibroblast-derived extracellular vesicles facilitate metastasis in hepatocellular carcinoma by delivering CTGF.  Cell Oncol (Dordr). 2025 Jul 1. https:\/\/doi.org\/10.1007\/s13402-025-01085-2. Epub ahead of print. PMID: 40591224.","DOI":"10.1007\/s13402-025-01085-2"},{"key":"3050_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011648","author":"W Xu","year":"2025","unstructured":"Xu W, Weng J, Zhao Y, et al. FMO2(+) cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-011648.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3050_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12964-025-02256-2","volume":"23","author":"W Chen","year":"2025","unstructured":"Chen W, Li Y, Zhou Q, et al. The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC [J]. Cell Commun Signal. 2025;23(1):238.","journal-title":"Cell Commun Signal"},{"key":"3050_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101203","volume":"67","author":"S Wang","year":"2025","unstructured":"Wang S, Wu W, Shi Z, et al. SMYD2 epigenetically activates BMP4\/SMAD1\/5\/8\/ID3 axis to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma. Neoplasia. 2025;67: 101203.","journal-title":"Neoplasia"},{"issue":"5","key":"3050_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101329","volume":"7","author":"C Zhang","year":"2025","unstructured":"Zhang C, Zhou Y, Hu M, et al. PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating the NF-\u03baB\/IL-6\/STAT3-dependent TCA cycle. JHEP Rep. 2025;7(5): 101329.","journal-title":"JHEP Rep"},{"issue":"1","key":"3050_CR56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):146.","journal-title":"Mol Cancer"},{"key":"3050_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116323","volume":"173","author":"KQ Li","year":"2024","unstructured":"Li KQ, Bai X, Ke AT, et al. Ubiquitin-specific proteases: from biological functions to potential therapeutic applications in gastric cancer. Biomed Pharmacother. 2024;173: 116323.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3050_CR58","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/abbs\/gmy084","volume":"50","author":"Q Zheng","year":"2018","unstructured":"Zheng Q, Fan H, Meng Z, et al. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription. Acta Biochim Biophys Sin. 2018;50(9):897\u2013904.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"3050_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41419-020-2487-z","volume":"11","author":"L Mei","year":"2020","unstructured":"Mei L, Shen C, Miao R, et al. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner. Cell Death Dis. 2020;11(4):270.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3050_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01021-5","volume":"9","author":"P Zhan","year":"2025","unstructured":"Zhan P, Cheng Y, Wu Y, et al. METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3. NPJ Precis Oncol. 2025;9(1): 234.","journal-title":"NPJ Precis Oncol"},{"key":"3050_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111585","volume":"127","author":"L Xie","year":"2025","unstructured":"Xie L, Song D, Ouyang Z, et al. USP27 promotes glycolysis and hepatocellular carcinoma progression by stabilizing PFKFB3 through deubiquitination. Cell Signal. 2025;127: 111585.","journal-title":"Cell Signal"},{"issue":"1","key":"3050_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s11658-025-00733-7","volume":"30","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Yuan Z, Huo Q, et al. YY1 induced USP13 transcriptional activation drives the malignant progression of hepatocellular carcinoma by deubiquitinating WWP1. Cell Mol Biol Lett. 2025;30(1):56.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"3050_CR63","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/liv.15479","volume":"43","author":"M Han","year":"2023","unstructured":"Han M, Liu F, Li X, et al. LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR\/ERK axis. Liver Int. 2023;43(2):471\u201389.","journal-title":"Liver Int"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03050-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03050-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03050-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:01:13Z","timestamp":1757440873000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03050-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3050"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03050-z","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Animal Ethical and Welfare Committee of The First Affiliated Hospital of Soochow University, and the study was conducted in accordance with the Declaration of Helsinki and the institutional guidelines for the use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors listed in this study have confirmed that they do not have any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"784"}}